Dexmedetomidine
XJTU1AF-CRF-2016T-09
Phase 1 small_molecule active
Quick answer
Dexmedetomidine for Heart Injuries is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Heart Injuries
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active